Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REgistry-based Randomized Controlled Trial of Treatment Duration and Mortality in Long-term OXygen Therapy (REDOX) A Multicenter, Phase IV, Registry-Based, Randomized Controlled Trial (R-RCT)

NCT03441204 is registered in ClinicalTrials.gov with Skane University Hospital as lead sponsor.

NCT NCT03441204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03441204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REgistry-based Randomized Controlled Trial of Treatment Duration and Mortality in Long-term OXygen Therapy (REDOX) A Multicenter, Phase IV, Registry-Based, Randomized Controlled Trial (R-RCT)
Lead sponsor
Skane University Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 16, 2018
Completion date
April 4, 2023
Enrollment
241 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic respiratory failure with hypoxia